MedPage Today August 5, 2024
Mike Bassett

— Colorectal cancer screening accounted for 64% of the total amount

The cost of initial cancer screening in the U.S. was estimated to be over $43 billion in 2021, which was less than the reported annual cost of cancer treatment in the first year after diagnosis, according to a modeling study.

Using national healthcare survey and cost resources data, the total healthcare system costs for initial breast, cervical, colorectal, lung, and prostate cancer screening were estimated at $43.2 billion in 2021, reported Michael T. Halpern, MD, PhD, of the National Cancer Institute, and colleagues.

Of note, colorectal cancer screening accounted for 63.6% of the total amount, at $27.5 billion, with screening colonoscopy representing about 55% of the total, they noted...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Patient / Consumer, Provider, Survey / Study, Trends
Social epidemics and the role of physicians
The risk of a bird flu pandemic is rising
The growing impact of behavioral health platforms in meeting mental health care needs
ChatGPT outperformed doctors again? Pitfalls of reporting AI progress
Patient Portals 4.0: Future of Patient Engagement

Share This Article